02 03-05-12 overview of rheumatic diseases color

Upload: luke-truong

Post on 06-Apr-2018

219 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    1/76

    OVERVIEW OFRHEUMATIC DISEASES

    Elaine M. Greifenstein, MD

    Clinical Associate Professor

    Internal Medicine

    Susan Bruce, PharmD, BCPS

    Associate Professor & Chair

    Pharmacy Practice

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    2/76

    Concept Map

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    3/76

    Rheumatologic Diseases (1)

    Mainly involve the musculoskeletal system May be self-limited or localized problems

    improve with symptomatic treatment

    ex: bursitis, tendinitis, strains, sprains

    May require urgent diagnosis & treatment

    ex: septic arthritis, crystal-induced arthritis, temporal arteritis

    Often accompanied by systemic features

    malaise & fatigue, fever, weight loss

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    4/76

    Rheumatologic Diseases (2)

    Often accompanied by multi-organ systeminvolvement

    hematologic

    skin eye

    lung

    kidney Challenging to diagnose

    Complicated to treat at times

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    5/76

    Rheumatologic Diseases (3)

    May be the presenting complaint in neoplasticdiseases & endocrinopathies

    Comprehensive history & physical are essential to

    diagnosis! diagnosis can be made 75% of the time on H&P alone

    Serologies used to support diagnosis

    should be used judiciously to avoid false-positive results

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    6/76

    Insert figure 331-1

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    7/76

    COMMON RHEUMATICDISEASES

    OsteoarthritisRheumatoid arthritis (RA)

    Systemic lupus erythematosus (SLE)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    8/76

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    9/76

    Osteoarthritis

    Degenerative joint disease

    DJD

    Second leading cause of adults receiving SocialSecurity Disability payments in US

    Estimated 59.4 million Americans affected by 2020 Prevalence increases with age

    Caused by multiple factors: macro & micro trauma,

    genetics, biochemical changes, inflammation &mechanical forces

    Cartilage failure imbalance of dynamic degradative& repair process in cartilage, synovium & bone

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    10/76

    Rheumatoid Arthritis (RA)

    An inflammatory arthritis commonly presenting as asymmetric polyarthritis

    Associated with significant morning stiffness

    Affects approximately 1% of the population

    Significant morbidity & mortality

    Women to men 3:1

    Suspected familial predisposition

    Etiology unknown, but inflammatory process causing

    damage being elucidated

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    11/76

    Systemic Lupus Erythematosus (SLE)

    Multi-systemic inflammatory connective tissue disease Unknown etiology, but humoral & cellular immuneabnormalities exist

    Clinical manifestations range from mild to life-threatening Clinical course characterized by acute & chronicexacerbations & remissions

    Most common between ages of 15 & 40 years Women to men 8:1

    Prevalence of 1/1,000 population

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    12/76

    From: Rheumatology Image Bank byAmerican College of Rheumatology

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    13/76

    OTHER RHEUMATICDISEASES

    Other ArthritidesConnective Tissue Diseases

    Vasculitides

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    14/76

    Other Arthritides

    Crystalline arthritis gout

    pseudogout/CPPD

    Seronegative spondyloarthropathies psoriatic arthritis

    ankylosing spondylitis

    reactive arthritis enteropathic arthritis

    undifferentiated spondyloarthropathy

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    15/76

    Connective Tissue Diseases

    Inflammatory myopathies(polymyositis/dermatomyositis)

    Sjgrens syndrome

    Scleroderma (systemic sclerosis/CREST syndrome) Mixed connective tissue disease

    Antiphospholipid antibody syndrome

    Adult-onset Stills disease

    Relapsing polychondritis

    Sarcoid arthropathy

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    16/76

    Vasculitides

    Takayasus arteritis

    Giant cell arteritis (Temporal arteritis)

    Polymyalgia rheumatica

    Polyarteritis nodosa

    Wegeners granulomatosis

    Churg-Strauss syndrome

    Microscopic polyangiitis

    Henoch-Schnlein purpura

    Cryoglobulinemic vasculitis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    17/76

    CLASSIFICATION OFRHEUMATIC DISEASES

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    18/76

    CLASSIFICATION

    Inflammatory Disorders

    Versus

    Non-Inflammatory Disorders

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    19/76

    Inflammatory Disorders (1)

    Characterized by: systemic symptoms

    fever, stiffness, weight loss, malaise & fatigue

    signs of joint inflammation on physical exam

    erythema, warmth, swelling, pain

    lab evidence of inflammation

    elevated ESR, elevated CRP, decreased albumin, elevated platelets

    joint stiffness common after prolonged rest (morning stiffness)

    duration > 1 hour suggests an inflammatory disorder

    improves with activity

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    20/76

    Inflammatory Disorders (2)

    May be immune-mediated: systemic lupus erythematosus (SLE)

    rheumatoid arthritis (RA)

    May be reactive: reactive arthritis (ReA) / Reiters syndrome

    May be infectious:

    gonococcal arthritis (GC arthritis)

    May be crystal-induced:

    gout

    pseudogout (calcium pyrophosphate deposition CPPD)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    21/76

    Non-Inflammatory Disorders

    Characterized by: absence of systemic symptoms

    pain without erythema or warmth

    pain increases with use

    pain increases with weight-bearing

    normal lab tests

    joint stiffness

    stiffness < 1 hour, typically < 15 minutes

    common conditions

    osteoarthritis (OA), fibromyalgia, traumatic conditions

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    22/76

    Inflammatory Disorders Non-Inflammatory Disorders

    Symptoms

    Morning stiffness Prolonged > 1 hour Brief

    Peak discomfort After prolonged inactivity After prolonged use

    Constitutional Present Absent

    Locking/Instability Uncommon Implies internal derangement

    Symmetry Common Occasional

    Signs

    Tenderness Over entire exposed joint +/-, unusual

    Inflammation Common Unusual

    Multi-organ disease Often Absent

    Abnormal labs Often Absent

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    23/76

    CLASSIFICATION

    Articular Disorders

    Versus

    Non-Articular Disorders

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    24/76

    Articular Disorders (1)

    Pain may originate from articular structures: synovial membrane, cartilage, intra-articular ligaments,

    capsule, juxta-articular bone surfaces

    Pain may originate from periarticular structures: bursae, tendons, muscle, bone, nerve, skin

    Articular disorders:

    deep or diffuse pain worsens with active & passive movement

    physical exam deformity, warmth, swelling, effusion,crepitus

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    25/76

    From: Rheumatology Image Bank by American College of Rheumatology

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    26/76

    From: Rheumatology Image Bank by American College of Rheumatology

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    27/76

    Articular Disorders (2)

    Synovitis inflammation of synovial membrane that covers the joint

    boggy, tender swelling around the joints

    diagnosis requires palpation during physical exam can occur in any joint with a synovial lining

    easiest to detect in finger & wrist joints

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    28/76

    Non-Articular Disorders

    Non-articular disorders: usually have point tenderness

    usually have increased pain with active but not passive

    movement absence of deformity or swelling on physical exam

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    29/76

    Important History in Evaluation ofArthritis Symptoms

    Classification of arthritis symptoms based onhistory:

    acuteness of onset

    degree of inflammation of joints number of joints involved

    temporal pattern of joint involvement

    distribution of joint involvement age & sex of patient

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    30/76

    CLASSIFICATION

    Number &

    Pattern of Joints Involved

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    31/76

    Number of Joints Involved

    Acute monoarthritis suggests infection!

    others gout, crystal-induced arthritis, trauma

    Asymmetric oligoarticular arthritis (< 5 joints) particularly of lower extremities

    typical of OA or ReA

    Symmetric polyarticular arthritis (> or = 5 joints) typical of RA or SLE

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    32/76

    Temporal Pattern of Joint Involvement (1)

    Migratory pattern present in certain joints for a few days, then remits &

    reappears in other joints

    examples rheumatic fever, gonococcal arthritis, earlyLyme disease

    Additive pattern

    begins in few joints & persists with subsequent involvementin additional joints

    examples rheumatoid arthritis, systemic lupus

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    33/76

    Temporal Pattern of Joint Involvement (2)

    Intermittent pattern

    repetitive attacks of acute polyarthritis with remissionbetween attacks

    examples polyarticular gout, sarcoid arthritis, Reiterssyndrome/reactive arthritis, psoriatic arthritis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    34/76

    Distribution of Joint InvolvementDisease Common Joints Joints Spared

    Rheumatoid arthritis Wrist, MCP, PIP, elbow,

    glenohumeral, Cspine, hip,knee, ankle, MTP

    DIP, thoracolumbar spine

    Osteoarthritis 1st CMC, DIP, PIP, Cspine,thoracolumbar spine, hip,

    knee, 1st

    MTP, toe IP

    MCP, wrist, elbow, ankle

    Polyarticular gout 1st MTP, instep, heel,

    ankle, knee

    Axial, shoulder, hip

    Psoriatic arthritis Knee, ankle, MTP, toe IP,wrist, MCP, hand IP, axial

    Sarcoid arthritis Ankle, knee Axial

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    35/76

    Psoriatic Arthritis (1)

    Psoriatic arthritis (PsA): occurs in up to 10% of patients with psoriasis

    occurs equally in men & women

    mean age of onset 35-45 years other features: enthesitis, dactylitis, skin changes, & nail

    changes

    one of few inflammatory arthritides that can affect the DIPjoints

    enthesitis may present as heel & sole of foot pain

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    36/76

    Ankylosing Spondylitis (AS)

    Chronic inflammatory arthritis of the back morning stiffness > 1 hour & night pain

    involves articular joints of spine

    sacroiliac joints (SI joints)

    may be associated with peripheral arthritis of shoulders,hips, & knees

    possible extra-articular manifestations: anterior uveitis,fractures of fused spine, C1-2 subluxation, restrictive lung

    disease, aortic regurgitation

    Male to female ratio 3-9:1

    Strong association with HLA-B27

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    37/76

    Reactive Arthritis (Reiters Syndrome)

    Reactive arthritis (ReA): non-infectious arthritis

    occurs after a prior genitourinary (GU) infection or entericinfection with bloody diarrhea

    implicated organisms with initial infection:

    Chlamydia trachomatis

    Shigella, Salmonella, Campylobacter, Yersinia

    classic triad: uveitis, urethritis, arthritis (knees, ankles, feet) strongly associated with HLA-B27

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    38/76

    Age & Sex of Patient in Setting ofPolyarticular Symptoms

    Women aged 25-50 rheumatoid arthritis, systemic lupus, osteoarthritis,

    fibromyalgia

    Men aged 25-50 Reiters syndrome, ankylosing spondylitis, osteoarthritis,

    hemochromatosis

    Patients over age 50

    osteoarthritis, rheumatoid arthritis, CPPD disease,polymyalgia rheumatica, paraneoplastic syndrome

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    39/76

    APPROACH TOMONOARTHRITIS

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    40/76

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    41/76

    Features & Causes of Monoarthr it is (2)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    42/76

    Type Features Causes

    Trauma *Common*History is diagnostic*Rare in hospitalizedpatients

    *Fracture*Hemarthrosis*Internal derangement

    Avascular necrosis (AVN)of bone

    *Uncommon*More common in hip,knee, shoulder

    *Risk factors includetrauma, corticosteroid use,alcohol use/abuse

    Tumors *Uncommon *Benign or malignant

    *Primary or metastatic

    Systemic diseases withmonoarticular onset

    *Uncommon*Follow-up over time maybe necessary for diagnosis

    *Psoriatic arthritis*SLE*Reactive arthritis

    *RA

    Features & Causes of Monoarthr it is (2)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    43/76

    ARTHROCENTESIS &SYNOVIAL FLUID ANALYSIS

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    44/76

    ARTHROCENTESIS

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    45/76

    Indications for Arthrocentesis

    Suspected infection Suspected crystalline disease

    Post-traumatic effusion (to rule out hemarthrosis)

    New effusions of uncertain diagnosis Pain relief for large or tense effusions

    Intra-articular steroid injections for treatment

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    46/76

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    47/76

    Possible Complications of Arthrocentesis

    Bleeding (local hematoma or hemarthrosis) Iatrogenic infection (rare; 1:50,000 procedures)

    Rupture of tendon or periarticular structure

    Nerve damage Allergic reaction to injected medications

    Post-injection flare

    SC atrophy due to steroids (more common withfluoridated steroids)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    48/76

    SYNOVIAL FLUIDANALYSIS

    General Evaluat ion of Synovial Flu id

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    49/76

    Exam Normal Non-

    inflammatory

    Inflammatory Septic Hemorrhagic

    Viscosity High High Low Variable Variable

    Color Colorless tostraw

    Straw to yellow Yellow Variable Bloody

    Clarity Transparent

    (can readthroughfluid)

    Transparent Cloudy Opaque Opaque

    WBCs 50,000>95%

    PMN

    RBCs>>WBCs

    Diff Dx OA, SLE, AVN,trauma, tumors

    RA, PsA, ReA,crystal arthritis,SLE, infections

    Bacteria,AFB,fungi, RA

    Trauma,hemophilia,PVN

    General Evaluat ion of Synovial Flu id

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    50/76

    APPROACH TOPOLYARTHRITIS

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    51/76

    Patient Case (1) 34-year-old African American woman presents with a

    3-month history of joint pain, stiffness, & swelling Reports wrists, fingers, knees and feet are involved

    Initially had 30 minutes of morning stiffness, but now

    has progressed to 2 hours Had similar episode which lasted several weeksabout 2 months after her second pregnancy 2 years

    ago treated with an Rx NSAID & acute episoderesolved

    Using OTC ibuprofen 800mg tid without relief

    Malar rash is present

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    52/76

    Patient Case (2)

    Denies any other medical illnesses or

    hospitalizations

    Sexually active monogamous without any history

    of sexually transmitted disease

    Denies fevers, infections, alopecia, oral ulcers,

    conjunctivitis, iritis, pleuritic chest pain, pericarditis,Raynauds, alopecia, sicca symptoms, diarrhea,blood in stool, muscle weakness, jaundice,hepatitis, blood transfusions, or illicit drug use

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    53/76

    Patient Case (3)

    Afebrile with normal vital signs

    Heart & lungs normal without rubs

    Abdomen normal without hepatosplenomegaly

    ENT exam normal Mild synovitis & tenderness of dorsal wrists, MCPjoints, PIP joints, & MTP joints with guarded range of

    motion Painful knee ROM bilaterally with small effusions &diffuse warmth

    Di C l P i i h Ch i

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    54/76

    Diseases Commonly Presenting with Chronic

    Inflammatory Polyarticular Symptoms

    Rheumatoid arthritis

    Polyarticular JRA

    Systemic lupus

    Scleroderma Polymyositis

    Polymyalgia rheumatica

    Psoriatic arthritis Vasculitis

    Reiters syndrome

    Enteropathic arthritis Polyarticular gout

    CPPD disease

    Sarcoid arthritis Chronic viral hepatitis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    55/76

    Diseases Commonly Presenting with Chronic Non-

    Inflammatory Polyarticular Symptoms

    Osteoarthritis

    CPPD disease

    Tophaceous gout

    Benign hypermobility joint syndrome

    Pagets disease

    Fibromyalgia

    Hemochromatosis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    56/76

    LABORATORY EVALUATIONOF RHEUMATIC DISEASES

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    57/76

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    58/76

    Erythrocyte Sedimentation Rate (ESR) (1)

    Measurement of rate of erythrocyte settling inanticoagulated blood

    Nonspecific marker of tissue inflammation

    ESR cannot distinguish if underlying cause is:

    Infectious

    Inflammatory

    Paraneoplastic

    Patients with ESR > 100 mm/hr generally have one of thefollowing:

    connective tissue disease

    infection (classically TB or osteomyelitis)

    malignancy (often metastatic)

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    59/76

    Erythrocyte Sedimentation Rate (ESR) (2)

    Sometimes used to monitor activity of inflammatoryconditions like RA or SLE

    Variables which tend to raise the ESR include:

    Renal disease

    Diabetes

    Female sex

    Pregnancy

    Increasing ageESR may be lowered by:

    Heart failure

    Sickled erythrocytes

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    60/76

    C-Reactive Protein (CRP)

    Acute phase protein synthesized in response to tissueinjury

    Serum concentration change more quickly than ESR (mayincrease within 4-6 hours and normalize in a week)

    May provide prognostic information in patients with RAwhen sustained elevations present

    associated with radiographic progression

    associated with long-term disability

    May be elevated in obesity, diabetes, CAD, & malignancy

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    61/76

    Antinuclear Antibodies (ANA)

    Diverse group of autoantibodies that react withantigens in the cell nucleus

    Different patterns reflect different nuclear components

    Should only be ordered after complete history &physical examination & differential diagnosis generated

    Presence or absence must be interpreted within theclinical context of the patient

    Titers do not necessarily correlate with disease activity

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    62/76

    ANA Sensitivity

    SLE - >95%

    MCTD - >95%

    Sjgrens syndrome 75%

    Polymyositis/dermatomyositis - >75% Scleroderma - >60-90%

    RA 15-35%

    Anti-centromere staining pattern CREST >90%

    Absence of ANA virtually excludes diagnosis of SLE,but presence does not establish diagnosis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    63/76

    Significance of Positive ANA in

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    64/76

    Significance of Positive ANA inChronic Polyarticular Symptoms (2)

    Medication history may reveal medicationsassociated with drug-induced lupus (examples:procainamide, hydralazine)

    Other diseases associated with positive ANA: autoimmune thyroid disease

    chronic viral hepatitis

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    65/76

    Specific Autoantibodies (1)

    Type Description Clinical Association

    Anti-dsDNA Antibodies to doublestranded DNA

    SLE (often correlates with more active,severe disease)

    Anti-histone 5 types exist SLE, drug-induced SLE

    Anti-ENA Sm (Smith)

    RNP (ribonucleoprotein)RNA-protein complexes

    SLE

    Mixed connective tissue dxHigher prevalence in AA and Asian

    patients

    Anti-SSA (Ro) Ribonucleoproteins SLE, Sjogrens syndrome

    Anti-SSA (La) Ribonucleoproteins Sjogrens syndrome, SLE

    Anti-centromere Antibody to centromereregion of chromosome

    Limited scleroderma

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    66/76

    Specific Autoantibodies (2)

    Type Description Clinical Association

    Anti-Scl 70 Antibodies to DNAtopoisomerase 1

    Diffuse scleroderma

    Anti-Jo 1 Antibody to histidyl tRNA

    synthetase

    poly/dermatomyositis; patients tend to

    have interstitial lung disease, Raynauds,

    arthritisAnti-SRP Antibody to signal

    recognition proteinCardiomyopathyPoor prognosis

    Anti-PM-Scl Antibody to nucleolargranular component

    Polymyositis/scleroderma overlapsyndrome

    Anti-Mi-2 Antibodies to nucleolarantigen of unknownfunction

    DermatomyositisFavorable prognosis

    Antineutrophil Cytoplasmic Antibody

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    67/76

    Antineutrophil Cytoplasmic Antibody

    (ANCA)

    2 staining patterns:

    Cytoplasmic (C-ANCA)

    Highly sensitive and specific for Wegeners granulomatosis

    Perinuclear (P-ANCA)

    Associated with miscroscopic polyangiitis & Churg-Strauss Syndrome

    Correlate with disease activity

    Positive results may be caused by:

    Infection Medications (propylthiouricil)

    Other autoimmune diseases

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    68/76

    Rheumatoid Factor

    Polyclonal autoantibodies directed against Fc portion ofimmunoglobulins (IgG)

    Most commonly an IgM directed against IgG

    Associated with chronic inflammatory diseases

    80% sensitivity RA50% sensitivity scleroderma

    also seen in:

    Wegeners granulomatosis

    endocarditis

    chronic hepatitis

    chronic infection

    sarcoidosis

    malignancy

    Significance of Rheumatoid Factor in Chronic

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    69/76

    Significance of Rheumatoid Factor in Chronic

    Polyarticular Symptoms

    RF positive eventually in 75-85% of patients withrheumatoid arthritis

    RF may only be seen in 25% of patients with early

    rheumatoid arthritis (consider anti-CCP anticycliccitrullinated peptide)

    RF has low sensitivity & specificity for rheumatoid

    arthritis in ACUTE polyarticular syndromes RF can be positive in acute infections (hepatitis B,hepatitis C, EBV)

    Anti-Cyclic Citrullinated Peptide

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    70/76

    Anti Cyclic Citrullinated Peptide

    (anti-CCP)

    Autoantibodies directed against the amino acids formedby the posttranslational modification of arginine

    Role in the pathogenesis of RA?

    35% of patients will be positive in early rheumatoidarthritis when RF is negative

    A positive anti-CCP test can rule in rheumatoid arthritis,

    but a negative test cannot rule out rheumatoid arthritis

    For rheumatoid arthritis, specificity 95%, sensitivity 70%

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    71/76

    Myositis

    Creatinine phosphokinase (CPK)

    Myositis-specific antibodies

    sensitivities for inflammatory myopathies is low anti-Jo-1

    anti-signal recognition particle (anti-SRP)

    anti-Mi-2

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    72/76

    RAYNAUDSPHENOMENON

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    73/76

    Raynauds Phenomenon (1)

    Raynauds phenomenon:

    characterized by episodic digital ischemia

    sequential development of digital blanching, cyanosis &rubor (triphasic color response) following cold exposure &

    subsequent rewarming typically one or more digits will appear white on cold

    exposure

    separated into two categories: primary or idiopathic Raynauds disease

    secondary associated with other disease states or known causes ofvasospasm

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    74/76

    Raynauds Phenomenon (2)

    Raynaud

    s Disease: women are affected 5x more than men

    usually between age 20 & 40

    fingers involved more frequently than toes

    have milder forms of Raynauds phenomenon

    between attacks, digits may appear normal

    secondary causes of Raynauds phenomenon have been

    ruled out first

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    75/76

    Raynauds Phenomenon (3)

    Secondary Raynauds phenomenon causes:

    connective tissue diseases arterial occlusive disease

    pulmonary hypertension

    neurologic disorders blood dyscrasias

    trauma

    drugs ergots

    bleomycin, vinblastine, cisplatin

    beta-blockers

  • 8/2/2019 02 03-05-12 Overview of Rheumatic Diseases Color

    76/76

    Raynauds Phenomenon (4)

    Raynauds phenomenon treatment:

    reassurance if mild

    avoid unnecessary cold exposure

    warm clothing; gloves, mittens & hat

    tobacco use is contraindicated

    drug treatment if local measures unsuccessful calcium channel blockers (ex: nifedipine)

    alpha-1 adrenergic antagonists (ex: prazosin) surgical sympathectomy, if unresponsive to other

    measures